Abstract:
The present invention relates to a fibrinogenase cel-KG26 gene derived from rumen microorganisms of a black goat and uses thereof, and more specifically, to a cel-KG26 gene which is a novel fibrinogenase selected from rumen microorganisms of a black goat and a method of providing protein products thereof and manufacturing feed additives, a detergent composition, and biofuel by using the same. According to the present invention, by selecting a cel-KG26 gene which is a novel fibrinogenase gene derived from the rumen microorganisms of a black goat and providing a fibrinogenase cel-KG26 gene and protein products therethrough, it can be used for developing low-priced feed additives, softener, and detergent and actively used for production of biofuel by decomposing fibrins which are rich sources.
Abstract:
The present invention relates to a knock-in vector that can target a complement regulatory protein (decay accelerating factor, DAF) gene and a human alpha 1,2-fucosyltransferase (HT) gene in a position of an alpha 1,3-galactosyl transferase (alpha 1,3-GT) gene, a cell transduced with the vector, a fertilized egg that is nuclear transplanted in the cell, a transgenic animal that is knocked out by the vector, and a method for producing the same. The knock-in vector of the present invention can be used to produce a transgenic animal in which hyperacute rejection that occurs in xeno-transplantation is controlled, so that the knock-in vector can be widely used for the production of a transgenic animal that can be used for effective xeno-transplantation.
Abstract:
PURPOSE: A pharmaceutical composition containing human G-CSF mutant is provided to reduce administration amount and number. CONSTITUTION: A pharmaceutical composition for treating ischemic diseases contains the G-CSF mutant which is modified by substitution of 140th amino acid residue of human G-CSF, from phenylalanine(F) to asparagine(N). The human G-CSF is G-CSFb. The pharmaceutical composition further contains a carrier or excipient. The pharmaceutical composition also contains suspension, stabilizing agent, isotonizing agent, preservative, anti-adsorbing agent, surfactant, pH adjusting agent, analgesia agent, or anti-oxidant agent.
Abstract:
본 발명은 흑염소 반추위 미생물 유래의 자일라나아제 활성 효소 cel10-CBM6-KG60 유전자 및 이의 용도에 관한 것으로, 보다 구체적으로 흑염소 반추위 미생물로부터 선별한 신규한 자일라나아제 활성 효소 유전자인 cel10-CBM6-KG60 유전자 및 이의 단백질 산물을 제공하고, 이를 이용하여 사료첨가제, 세제 조성물 및 바이오연료를 제조하는 방법에 관한 것이다. 본 발명에 따르면, 흑염소 반추위 미생물로부터 신규한 자일라나아제 활성 효소 유전자인 cel10-CBM6-KG60 유전자를 선별할 수 있으며, 이를 통해 자일라나아제 활성 효소 cel10-CBM6-KG60 유전자 및 단백질 산물을 제공함으로써 저가의 사료 첨가제 개발에 이용할 수 있고, 섬유 유연제 및 세제 개발뿐만 아니라 풍부한 자원인 자일란을 분해하여 바이오연료의 생산에도 적극적으로 이용할 수 있다.
Abstract:
본 발명은 흑염소 반추위 미생물 유래의 섬유소분해효소 cel-KG36 유전자 및 이의 용도에 관한 것으로, 보다 구체적으로 흑염소 반추위 미생물로부터 선별한 신규한 섬유소분해효소 유전자인 cel-KG36 유전자 및 이의 단백질 산물을 제공하고, 이를 이용하여 사료첨가제, 세제 조성물 및 바이오연료를 제조하는 방법에 관한 것이다. 본 발명에 따르면, 흑염소 반추위 미생물로부터 신규한 섬유소분해효소 유전자인 cel-KG36 유전자를 선별할 수 있으며, 이를 통해 섬유소분해효소 cel-KG36 유전자 및 단백질 산물을 제공함으로써 저가의 사료 첨가제 개발에 이용할 수 있고, 섬유 유연제 및 세제 개발뿐만 아니라 풍부한 자원인 섬유소를 분해하여 바이오연료의 생산에도 적극적으로 이용할 수 있다.
Abstract:
본 발명은 흑염소 반추위 미생물 유래의 섬유소분해효소 cel-KG11 유전자 및 이의 용도에 관한 것으로, 보다 구체적으로 흑염소 반추위 미생물로부터 선별한 신규한 섬유소분해효소 유전자인 cel-KG11 유전자 및 이의 단백질 산물을 제공하고, 이를 이용하여 사료첨가제, 세제 조성물 및 바이오연료를 제조하는 방법에 관한 것이다. 본 발명에 따르면, 흑염소 반추위 미생물로부터 신규한 섬유소분해효소 유전자인 cel-KG11 유전자를 선별할 수 있으며, 이를 통해 섬유소분해효소 cel-KG11 유전자 및 단백질 산물을 제공함으로써 저가의 사료 첨가제 개발에 이용할 수 있고, 섬유 유연제 및 세제 개발뿐만 아니라 풍부한 자원인 섬유소를 분해하여 바이오연료의 생산에도 적극적으로 이용할 수 있다.
Abstract:
The present invention relates to a fibrinogenase cel-KG49 gene derived from rumen microorganisms of a black goat and uses thereof, and more specifically, to a cel-KG49 gene which is a novel fibrinogenase selected from rumen microorganisms of a black goat and a method of providing protein products thereof and manufacturing feed additives, a detergent composition, and biofuel by using the same. According to the present invention, a cel-KG49 gene which is a novel fibrinogenase gene derived from the rumen microorganisms of a black goat can be selected, and by providing the fibrinogenase cel-KG49 gene and protein products therethrough, they can be used for developing low-priced feed additives, softener, and detergent and actively used for production of biofuel by decomposing fibrins which are rich sources.
Abstract:
The present invention relates to a fibrinogenase cel-KG25 gene derived from rumen microorganisms of a black goat and uses thereof, and more specifically, to a cel-KG25 gene which is a novel fibrinogenase selected from rumen microorganisms of a black goat and a method of providing protein products thereof and manufacturing feed additives, a detergent composition, and biofuel by using the same. According to the present invention, it is possible to select a cel-KG25 gene which is a novel fibrinogenase gene derived from the rumen microorganisms of a black goat, and by providing the fibrinogenase cel-KG25 gene and protein products therethrough, they can be used for developing low-priced feed additives, softener, and detergent and actively used for production of biofuel by decomposing fibrins which are rich sources.
Abstract:
The present invention relates to a fibrinogenase cel-KG48 gene derived from rumen microorganisms of a black goat and uses thereof, and more specifically, to a cel-KG48 gene which is a novel fibrinogenase gene selected from rumen microorganisms of a black goat and a method of providing protein products thereof and manufacturing feed additives, a detergent composition, and biofuel by using the same. According to the present invention, a cel-KG48 gene which is a novel fibrinogenase gene derived from the rumen microorganisms of a black goat can be selected, and by providing the fibrinogenase cel-KG48 gene and protein products therethrough, they can be used for developing low-priced feed additives, softener, and detergent and actively used for production of biofuel by decomposing fibrins which are rich sources.